ATH 25.0% 0.3¢ alterity therapeutics limited

PBT2 for Middle Ear Infections, page-17

  1. 2,842 Posts.
    lightbulb Created with Sketch. 995
    iminvestor101, I just wonder if you also could call to UniQuest Communications, Brooke Baskin, [email protected], +61 7 3365 7480, +61 409767199. A phone call could give more info than an e-mail.

    Uniquest is : Australia's leading research commercialisation company

    "We commercialise UQ research to create change and deliver solutions for a better world".

    I am sure Uniquest is not waiting for the possible activity of ATH sometime in the future. I am sure they are negotiating right now. PBT2 will bring money to the university.

    Uniquest claims claims that: "Our commercialisation impact makes UQ Australia’s leading university for licence income and value of equity held in spin-out companies".



 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.